Skip to main content
Clinical Trials/NCT04992806
NCT04992806
Unknown
Not Applicable

A Retrospective Study on the Effect of Arthroscopy on Hip Diseases

Peking University Third Hospital1 site in 1 country600 target enrollmentJune 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Femoroacetabular Impingement
Sponsor
Peking University Third Hospital
Enrollment
600
Locations
1
Primary Endpoint
The patient was followed up at 1 year after surgery to evaluate the Visual Analog Scale (VAS).
Last Updated
4 years ago

Overview

Brief Summary

To study the effect of arthroscopy on the treatment of hip diseases and to evaluate the regularity and treatment of hip joint diseases.

Detailed Description

To study the clinical effect of arthroscopic treatment in patients with hip disease, a retrospective study was conducted on 600 patients with hip disease from January 2011 to January 2016. All patients underwent preoperative examinations. These included preoperative supine anteroposterior hip radiographs, cross-lateral radiographs, computed tomography (CT), and magnetic resonance imaging.Preoperative patient-reported outcomes (PROs), including visual analogue scale (VAS), international hip prognostic instrument-12 (IHOT-12), and modified Harris hip score (MHHS), were evaluated at 1, 2, and 5 years after surgery.

Registry
clinicaltrials.gov
Start Date
June 1, 2020
End Date
December 1, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The patient received imaging examination before surgery and was diagnosed with hip joint labrum injury, FAI and other hip joint diseases, and the patient complained of pain in the hip joint, buttocks or thigh. Conservative treatment is ineffective for more than 6 months.

Exclusion Criteria

  • History of hip surgery, hip osteoarthritis, femoral head necrosis, hip infection, rheumatic disease, lumbar disease, ankylosing spondylitis, or sacroiliac joint disease.

Outcomes

Primary Outcomes

The patient was followed up at 1 year after surgery to evaluate the Visual Analog Scale (VAS).

Time Frame: 1 year after operation

Visual Analog Scale (VAS), The highest score was 10, and the lowest was 0. The higher the score, the more obvious the pain.

The patient was followed up at 2 years after surgery to evaluate the Visual Analog Scale (VAS).

Time Frame: 2 years after operation

Visual Analog Scale (VAS), The highest score was 10, and the lowest was 0. The higher the score, the more obvious the pain.

The patient was followed up at 5 years after surgery to evaluate the Visual Analog Scale (VAS).

Time Frame: 5 years after operation

Visual Analog Scale (VAS), The highest score was 10, and the lowest was 0. The higher the score, the more obvious the pain.

Secondary Outcomes

  • The patient was followed up at 1 year after surgery to evaluate the International Hip Outcome Tool-12 (iHOT-12).(1 year after operation)
  • The patient was followed up at 2 years after surgery to evaluate the International Hip Outcome Tool-12 (iHOT-12).(2 years after operation)
  • The patient was followed up at 5 years after surgery to evaluate the International Hip Outcome Tool-12 (iHOT-12).(5 years after operation)
  • The patient was followed up at 1 year after surgery to evaluate modified Harris Hip Score (mHHS).(1 year after operation)
  • The patient was followed up at 2 years after surgery to evaluate modified Harris Hip Score (mHHS).(2 years after operation)
  • The patient was followed up at 5 years after surgery to evaluate modified Harris Hip Score (mHHS).(5 years after operation)

Study Sites (1)

Loading locations...

Similar Trials